Safety of Nonsteroidal Antiinflammatory Drugs in Patients with Cardiovascular Disease

@article{Danelich2015SafetyON,
  title={Safety of Nonsteroidal Antiinflammatory Drugs in Patients with Cardiovascular Disease},
  author={Ilya M Danelich and Sampaguita S Wright and Jennifer M. Lose and Brittany J Tefft and Jonathan D Cicci and Brent N. Reed},
  journal={Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year={2015},
  volume={35}
}
Nonsteroidal antiinflammatory drugs (NSAIDs) are used in the management of a variety of conditions, but their prevalence is likely underreported as a result of widespread availability and the perception that nonprescription therapies are unnecessary to report during medication history taking. However, NSAIDs are associated with a number of adverse effects, especially in patients with cardiovascular disease (CVD). Patients with CVD and comorbidities for which NSAIDs may provide symptomatic… Expand
Review: The choice and cardiovascular safety of particular nonsteroidal anti-inflammatory drugs
TLDR
It was observed that despite existing guidelines no single NSAID could be considered to be the safest one due to a lack of superiority trials and common adverse effects of NSAIDs. Expand
NSAIDs and Cardiovascular Toxicity
TLDR
Drug selection in individuals requiring chronic pain relief requires careful examination of the balance between cardiovascular and bleeding risks, and the development of additional, more selective NSAIDs has been halted. Expand
Aspectos de seguridad en el tratamiento del dolor con analgésicos antiinflamatorios no esteroideos
Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most consumed drugs worldwide, with or without medical prescription, mostly for the symptomatic treatment of a widely range of diseasesExpand
Overview of non-steroidal anti-inflammatory drugs (nsaids) in resource limited countries
TLDR
The COX-2 selective drugs are the newer drugs that have recently been made available in the drug market, and some examples include nimesulide, nabumatone, meloxicam, etodolac, celecoxib, and rofecoxib which have become popular amongst clinicians as they are generally considered to be more safe and tolerable, and at least equally efficacious with maximum therapeutic output. Expand
[The use of nonsteroidal anti - inflammatory drugs in polymorbid pathology].
TLDR
The literature review presents the possibilities of using non - steroidal anti - inflammatory drugs (NSAIDs) for polymorbid pathology and risk factors for the development of undesirable effects on the cardiovascular, digestive, urinary and other systems are considered. Expand
U.S. trends in prescription nonsteroidal anti‐inflammatory drug use among patients with cardiovascular disease, 1988–2016
TLDR
The use of prescription NSAIDs among U.S. adults with CVD from 1988 to 2016 is characterized to characterize the long-term trends in real‐world prescribing of NSAIDs within the CVD population. Expand
Naproxen in Pain and Inflammation – A Review
TLDR
It has been established that the duration of pain relief after a single dose of naproxen is significantly greater than after the intake of ibuprofen-containing products of equal concentration in the post-operative period of dental intervention. Expand
Respiratory Tract Infections, Nonsteroidal Anti-inflammatory Drugs and Acute Myocardial Infarction: Is Understanding Interaction Between Risk Factors the Key to Personalizing Prevention?
TLDR
Evidence is provided for a dual effect of acute respiratory infection and NSAIDs on myocardial infarction risk in a case crossover study of 9793 patients from Taiwan and a series of sensitivity analyses strengthened the validity of the results and reduced the risk of bias due to inappropriate control time-window selection. Expand
Cyclo‐oxygenase selectivity and chemical groups of nonsteroidal anti‐inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBase
TLDR
The reporting frequency of HSRs for NSAIDs based on their relative inhibitory potency toward COX enzymes and chemical groups, including the presence/absence of a functional sulfonamide group, in strata observed 5 years after market authorization is assessed. Expand
Chapter 6 – Rheumatoid Arthritis
TLDR
The pathogenesis of premature atherosclerosis in RA, the impact of disease-related factors on CV disease, the current recommendations about assessing and managing increased CV risk as well as a future research agenda are discussed. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 64 REFERENCES
Gastrointestinal Safety of Nonsteroidal Antiinflammatory Drugs and Selective Cyclooxygenase-2 Inhibitors in Patients on Warfarin
TLDR
In situations where patients require NSAIDs and cannot be managed using other therapies, the results suggest that selective COX-2 inhibitors are associated with fewer hospitalizations for GI bleeding. Expand
Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure.
TLDR
NSAIDs are frequently used in patients with HF and are associated with increased risk of death and cardiovascular morbidity, inasmuch as even commonly used NSAIDs exerted increased risk. Expand
Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study
TLDR
Most patients with OA requiring NSAIDs for pain control showed a high prevalence of GI and CV risk factors, such that the prescription of OA treatments should be very carefully considered. Expand
Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.
TLDR
The burden of illness resulting from NSAID-related CHF may exceed that resulting from gastrointestinal tract damage and was increased to a greater extent with long half- life than with short half-life drugs. Expand
A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure.
TLDR
In short-term use, NSAIDs vary considerably in their effect on blood pressure, and indomethacin and naproxen were associated with the largest increases in blood pressure. Expand
Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke.
TLDR
In the general population, it is found that a greater risk of stroke is found with current use of nonselective and COX-2-selective NSAIDs. Expand
Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis
TLDR
A stable estimate of the overall effect of various NSAIDs on blood pressure is produced to evaluate possible mechanisms by which NSAID therapy may alter blood pressure and to determine potential predisposing factors for this interaction. Expand
Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population.
TLDR
People on antihypertensive therapy taking NSAIDs had systolic blood pressures approximately 5 mmHg higher than those not takingNSAIDs, and were more likely to have syStolic blood pressure above 140mmHg (odds ratio = 2.19, 95% confidence interval 1.33, 3.61). Expand
Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors.
TLDR
In stable atherothrombosis patients, the use of NSAIDs appears to be independently associated with an increased cerebrovascular event risk. Expand
Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs
TLDR
NSAIDS should be used cautiously in patients who have other risk factors for UGIB; these include advanced age, smoking, history of peptic ulcer, and use of oral corticosteroids or anticoagulants. Expand
...
1
2
3
4
5
...